Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

BioPorto: Frasalg af antistofforretningen, konsekvenser for planer og kapital

BIOPOR09.04.2026, 15.57
Michael FriisHead of Equities

I forbindelse med offentliggørelsen af frasalg af BioPortos antistofforretning for op til USD 10,5 mio. satte vi os sammen med CEO Carsten Buhl og CFO Klaus Juhl Wulff for at se nærmere på nyheden. Prisniveau, strategiske konsekvenser frem mod 2028 og kapitalbehovet var blandt hovedemnerne.

HC Andersen Capital modtager betaling fra BioPorto for en Digital IR/Corporate Visibility abonnementsaftale. /Michael Friis 15:56  09/04-2026

Upcoming webcasts

Recent videos

Duell Q3'26: "Many good things to build upon"
15.10.2026, 11.33 Duell
Nordea third-quarter results 2026
15.10.2026, 10.00 Nordea
Mi
HCA Morgenbørs 15/10 - Fokus på AI-boble og AI-agenter i interview med Anders Bæk
15.10.2026, 09.48 Microsoft
Duell Oyj, Q4'26
15.10.2026, 09.30 Duell
Carasent, Audiocast, Q3'26
15.10.2026, 08.00 Carasent
View all videos